In addition to glycemic control and weight loss, certain GLP-1 receptor agonists have FDA-approved indications to lower the risk for major adverse cardiovascular events, address moderate to severe obstructive sleep apnea, and, most recently, reduce the risk for worsening kidney disease, kidney failure, and cardiovascular death
We serve clients from Folsom CA, Roseville CA, El Dorado Hills CA, Citrus Heights CA, Fair Oaks CA, Granite Bay CA, Rocklin CA, Rancho Cordova CA, Loomis CA, and surrounding areas
Tirzepatide comes in doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al